Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TMO Thermo Fisher Scientific Inc
- Stocks
- Healthcare
- NYSE: TMO
Price (delayed)
$405.08
Market cap
$152.92B
P/E Ratio
23.7
Dividend/share
$1.64
EPS
$17.09
Enterprise value
$182.97B
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .
Highlights
The stock's price to earnings (P/E) is 29% less than its last 4 quarters average of 33.3 and 26% less than its 5-year quarterly average of 31.8
The company's equity rose by 9% YoY
The debt has increased by 9% QoQ but it has decreased by 4% YoY
Key stats
What are the main financial stats of TMO
Market
Valuations
Earnings
Shares outstanding
377.49M
Market cap
$152.92B
Enterprise value
$182.97B
Price to earnings (P/E)
23.7
Price to book (P/B)
3.09
Price to sales (P/S)
3.57
EV/EBIT
22
EV/EBITDA
16.2
EV/Sales
4.27
Revenue
$42.9B
Gross profit
$17.73B
Operating income
$7.39B
Net income
$6.52B
EBIT
$8.32B
EBITDA
$11.29B
Free cash flow
$6.79B
Per share
Balance sheet
Liquidity
EPS
$17.09
EPS diluted
$17.05
Free cash flow per share
$17.96
Book value per share
$130.92
Revenue per share
$113.49
TBVPS
$98.48
Total assets
$99.04B
Total liabilities
$49.68B
Debt
$34.19B
Equity
$49.39B
Working capital
$10.2B
Debt to equity
0.69
Current ratio
1.77
Quick ratio
1.09
Net debt/EBITDA
2.66
Margins
Efficiency
Dividend
EBITDA margin
26.3%
Gross margin
41.3%
Net margin
15.2%
Operating margin
17.2%
Return on assets
6.6%
Return on equity
13.3%
Return on invested capital
15.8%
Return on capital employed
9.7%
Return on sales
19.4%
Dividend yield
0.4%
DPS
$1.64
Payout ratio
9.6%
TMO stock price
How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.58%
1 week
-0.84%
1 month
-1.69%
1 year
-29.19%
YTD
-22.13%
QTD
-18.59%
Financial performance
How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.9B
Gross profit
$17.73B
Operating income
$7.39B
Net income
$6.52B
Gross margin
41.3%
Net margin
15.2%
Thermo Fisher Scientific's net income has increased by 8% YoY and by 2.8% from the previous quarter
The net margin has increased by 7% YoY and by 2.7% QoQ
The operating income has grown by 6% YoY
Thermo Fisher Scientific's operating margin has increased by 4.9% YoY
Price vs fundamentals
How does TMO's price correlate with its fundamentals
Growth
What is Thermo Fisher Scientific's growth rate over time
Valuation
What is Thermo Fisher Scientific stock price valuation
P/E
23.7
P/B
3.09
P/S
3.57
EV/EBIT
22
EV/EBITDA
16.2
EV/Sales
4.27
The stock's price to earnings (P/E) is 29% less than its last 4 quarters average of 33.3 and 26% less than its 5-year quarterly average of 31.8
TMO's EPS is up by 9% year-on-year and by 3.1% since the previous quarter
The P/B is 37% below the 5-year quarterly average of 4.9 and 28% below the last 4 quarters average of 4.3
The company's equity rose by 9% YoY
The P/S is 32% below the 5-year quarterly average of 5.2 and 28% below the last 4 quarters average of 4.9
Efficiency
How efficient is Thermo Fisher Scientific business performance
TMO's ROA is up by 6% YoY and by 3.1% from the previous quarter
TMO's ROS is up by 3.2% year-on-year
Dividends
What is TMO's dividend history
DPS
$1.64
Dividend yield
0.4%
Payout ratio
9.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Thermo Fisher Scientific financials performed over time
The total assets is 99% greater than the total liabilities
The current ratio has increased by 7% since the previous quarter and by 4.1% year-on-year
Thermo Fisher Scientific's quick ratio has increased by 6% from the previous quarter
The debt is 31% lower than the equity
Thermo Fisher Scientific's debt to equity has decreased by 12% YoY but it has increased by 10% QoQ
The company's equity rose by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.